Mark DiSanto - 03 Dec 2025 Form 4 Insider Report for XCel Brands, Inc. (XELB)

Role
Director
Signature
/s/ Mark DiSanto
Issuer symbol
XELB
Transactions as of
03 Dec 2025
Net transactions value
+$50,557
Form type
4
Filing time
05 Dec 2025, 20:45:14 UTC
Previous filing
05 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DiSanto Mark Director C/O XCEL BRANDS, INC., 550 SEVENTH AVENUE, NEW YORK /s/ Mark DiSanto 05 Dec 2025 0001530941

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XELB Common Stock Award $14,257 +15,167 +196% $0.9400 22,917 03 Dec 2025 Direct F1
transaction XELB Common Stock Award $18,800 +20,000 +87% $0.9400 42,917 03 Dec 2025 Direct F2
transaction XELB Common Stock Purchase $17,500 +50,000 +17% $0.3500 337,018 05 Dec 2025 See Footnote F3
holding XELB Common Stock 8,239 03 Dec 2025 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XELB Stock Options Award $0 +36,500 $0.000000 36,500 03 Dec 2025 Common Stock 36,500 $0.9400 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of restricted stock awarded pursuant to a restricted stock agreement, which vests on March 31, 2026, provided that the reporting person may extend the vesting date as to all or a portion of the shares, one or more times, in six month increments, at his sole discretion.
F2 Represents shares awarded to Mr. DiSanto
F3 Represents shares held by the Mark X DiSanto Investment Trust, of which Mr. DiSanto is trustee as to which Mr. DiSanto has sole voting dispositive power.
F4 Represents shares held by other trusts, of which Mr. DiSanto is trustee as to which Mr. DiSanto has sole voting dispositive power.